Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.65M | 26.46M | 27.88M | 29.14M | 30.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 336.67M | 122.15M | 121.19M | 118.00M | 124.80M |
| Operating Income | -336.67M | -122.15M | -121.19M | -118.00M | -124.80M |
| Income Before Tax | -1.66B | -118.60M | -116.91M | -112.46M | -118.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.66K | -118.60 | -116.91 | -112.46 | -118.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.66B | -118.60M | -116.91M | -112.46M | -118.09M |
| EBIT | -336.67M | -122.15M | -121.19M | -118.00M | -124.80M |
| EBITDA | -332.09M | -118.74M | -117.66M | -114.44M | -121.20M |
| EPS Basic | -13.66 | -1.51 | -1.70 | -1.65 | -1.74 |
| Normalized Basic EPS | -8.39 | -0.94 | -1.06 | -1.03 | -1.09 |
| EPS Diluted | -13.66 | -1.51 | -1.70 | -1.65 | -1.74 |
| Normalized Diluted EPS | -8.39 | -0.94 | -1.06 | -1.03 | -1.09 |
| Average Basic Shares Outstanding | 388.59M | 331.61M | 274.82M | 272.64M | 271.78M |
| Average Diluted Shares Outstanding | 388.59M | 331.61M | 274.82M | 272.64M | 271.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |